(Press-News.org) Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth of tumor cells in prostate and other epithelial cancers.
This discovery is important because it may prove essential for creating new therapies that stop the growth of cancer, the researchers said. The study is featured on the cover of the Oct. 15 issue of the journal Genes and Development.
The Trop2 protein is expressed on the surface of many types of epithelial cancer cells — cells that form tumors that grow in the skin and the inner and outer linings of organs — but little was known about the protein's role in the growth and proliferation of cancer cells. The UCLA researchers discovered that Trop2 controls those processes through a mechanism that leads to the protein being cleaved into two parts, one inside the cell and one outside. This Trop2 division promotes self-renewal of the cancer cells, resulting in tumor growth.
"Determining the mechanism of this protein is important for planning treatments that stop the growth of prostate cancer, but it is also overexpressed in so many other types of cancer that it might be a treatment target for many more patients beyond that population," said senior author Witte, director of the Broad Center and a professor in the department of microbiology, immunology, and molecular genetics at UCLA.
The finding may have a critical clinical impact, the researchers said, since preventing the cleavage of Trop2 by mutating those sites on the protein where it splits eliminates the protein's ability to promote tumor cell growth. Using this knowledge, they said, new therapy strategies can be developed that block Trop2 molecular signaling, thus stopping its ability to enhance tumor growth in a variety of epithelial malignancies, including prostate, colon, oral cavity, pancreatic and ovarian cancers, among others.
"The reason I became interested in Trop2 was that it is highly expressed in many epithelial cancers but no one knew precisely how the protein worked to promote the disease," said Stoyanova, the study's first author and a postdoctoral scholar in the department of microbiology, immunology and molecular genetics at UCLA.
###
Funding for the study was provided by the California Institute for Regenerative Medicine Training Grant (TG2-01169), the U.S. Department of Defense Prostate Cancer Research Program (PC110638) and the Howard Hughes Medical Institute.
The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research: UCLA's stem cell center was launched in 2005 with a UCLA commitment of $20 million over five years. A $20 million gift from the Eli and Edythe Broad Foundation in 2007 resulted in the renaming of the center. With more than 200 members, the Broad Stem Cell Research Center is committed to a multidisciplinary, integrated collaboration among scientific, academic and medical disciplines for the purpose of understanding adult and human embryonic stem cells. The center supports innovation, excellence and the highest ethical standards focused on stem cell research with the intent of facilitating basic scientific inquiry directed toward future clinical applications to treat disease. The center is a collaboration of the David Geffen School of Medicine at UCLA, UCLA's Jonsson Cancer Center, the UCLA Henry Samueli School of Engineering and Applied Science and the UCLA College of Letters and Science.
For more news, visit the UCLA Newsroom and follow us on Twitter.
UCLA researchers reveal how 'cleaving' protein drives tumor growth in prostate, other cancers
2012-10-16
ELSE PRESS RELEASES FROM THIS DATE:
Young people driving epidemic of prescription drug abuse
2012-10-16
DENVER (Oct. 16, 2012) – A new study by the University of Colorado Denver reveals that today's adolescents are abusing prescription pain medications like vicodin, valium and oxycontin at a rate 40 percent higher than previous generations.
That makes it the second most common form of illegal drug use in the U.S. after marijuana, according to Richard Miech, Ph.D., lead author of the study and professor of sociology at CU Denver.
"Prescription drug use is the next big epidemic," Miech said. "Everyone in this field has recognized that there is a big increase in the abuse ...
Evidence does not support 3-strikes law as crime deterrent
2012-10-16
RIVERSIDE, Calif. — Contrary to what police, politicians and the public believe about the effectiveness of California's three-strikes law, research by a University of California, Riverside criminologist has found that the get-tough-on-criminals policy voters approved in 1994 has done nothing to reduce the crime rate.
In a rigorous analysis of crime in California and the nation, sociology professor Robert Nash Parker determined that crime has been decreasing at about the same rate in every state for 20 years, regardless of whether three-strikes policies are in place or ...
New radiation treatment significantly increases survival rate
2012-10-16
Arlington, Va. — A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D., from the University of Tennessee Health Science Center and Baylor College of Medicine, show that application of this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo.
Their work, which is funded through an NIH grant from the National Institute for Allergy ...
New dissolvable oral strip provides instant pain relief for burns
2012-10-16
Arlington, Va. — A dissolvable oral strip has been developed to immediately relieve pain from burns caused by ingestion of hot foods and liquids, such as coffee, pizza, and soup. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., on Oct. 14 – 18.
Lead researcher Jason McConville, Ph.D., and colleagues from University of Texas at Austin, designed the strip for controlled delivery of a local anesthetic, benzocaine, and ...
Great apes, small numbers
2012-10-16
Sumatran orangutans have undergone a substantial recent population decline, according to a new genetic study, but the same research revealed the existence of critical corridors for dispersal migrations that, if protected, can help maintain genetic diversity and aid in the species' conservation.
One of two species of orangutans, the Sumatran orangutan is classified as "critically endangered" by the IUCN Red List. Once widespread on the island of Sumatra, only an estimated 6,600 individuals remain, restricted to small forest patches on the northern tip of the island. Recent ...
Novel insights into the physical basis of sickle cell disease could lead to better treatments
2012-10-16
Sickle cell disease—the most common inherited blood disorder in the United States—causes red blood cells to distort into a crescent shape and block small blood vessels. New insights into how these abnormal cells disrupt circulation could lead to more effective treatment strategies, as revealed by a study published by Cell Press in the October 17th issue of Biophysical Journal.
"Sickle cell disease entails a central mechanical component, since the circulation gets blocked," explains senior study author Frank Ferrone of Drexel University. "We now finally understand how ...
Prion protein hints at role in aiding learning and memory
2012-10-16
Scientists from the University of Leeds have found that the protein called prion helps our brains to absorb zinc, which is believed to be crucial to our ability to learn and the wellbeing of our memory.
The findings published today (Tuesday 16 October) in Nature Communications show that prion protein regulates the amount of zinc in the brain by helping cells absorb it through channels in the cell surface. It is already known that high levels of zinc between brain cells are linked with diseases such as Alzheimer's and Parkinson's.
Professor Nigel Hooper from the University's ...
Boreal forest bends to development but there is a breaking point
2012-10-16
(Edmonton) Northern Alberta's boreal forest shows a surprising resiliency to human intrusion, but University of Alberta researchers warn the landscape has a definite breaking point.
The U of A research team led by graduate student Stephen Mayor found that up to a certain point plant life in the boreal forest responded to intrusions such as roadways and farm fields by actually increasing its biodiversity.
The researchers, counted plant species in sites across the whole of northern Alberta, an area larger than Germany. Then satellite and aerial photos were used to ...
Study advances understanding of volcanic eruptions
2012-10-16
Volcanic eruptions vary from common, small eruptions that have little impact on humans and the environment to rare, large-to-gigantic eruptions so massive they can threaten civilizations.
While scientists don't yet fully understand the mechanisms that control whether an eruption is large or small, they do know that eruptions are driven by the rapid expansion of bubbles formed from water and other volatile substances trapped in molten rock as it rises beneath a volcano. The mechanism is much the same as that involved in shaking a bottle of a carbonated drink and then ...
2-gene test predicts which patients with heart failure respond best to beta-blocker drug
2012-10-16
Tampa, FL (Oct. 16, 2012) -- A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
The study, drawing upon a randomized placebo-controlled trial for the beta blocker bucindolol, apprears this month in the online international journal PLoS ONE. In addition to Dr. Liggett, whose laboratory discovered and characterized the two genetic variations, Christopher O'Connor, ...